Rates of Respiratory Viral Infection in Pediatric Lung Transplant Patients After ATG vs. Basiliximab Induction

被引：0
|
作者：
Henderson, C. [1 ]
Nicholas, S. [1 ]
Munoz-Rivas, F. [1 ]
Melicoff-Portillo, E. [1 ]
Das, S. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5133
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Mortality after pediatric lung transplantation: Autopsies vs. clinical impression
    Kaditis, AG
    Phadke, S
    Dickman, P
    Webber, S
    Kurland, G
    Michaels, MG
    PEDIATRIC PULMONOLOGY, 2004, 37 (05) : 413 - 418
  • [42] Outcomes of Thymoglobulin vs. Basiliximab Induction Therapies in 2DR Mismatch Living-Donor Renal Transplant Recipients
    Mohamed, Mahmoud M.
    Raza, Hafiz Muhammad Ali
    Ali, Hatem
    Malik, Shafi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 651 - 651
  • [43] Viral Infection Rates and Associated Serious Complications in Pediatric Umbilical Cord Blood Transplant Patients over the Last Decade
    Lau, Calvin
    DiTullio, David
    Bowles, LaVette
    Moore, Theodore B.
    De Oliveira, Satiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [44] Retrospective Analysis Of Lung Transplant Patients With Pulmonary Hypertension: Comparison Of Patients With Double-Lung Vs. Heart-Lung Transplant
    Kolodziejski, P.
    Kesavan, R.
    Parulekar, A.
    Noon, G.
    Loebe, M.
    LaFrancesca, S.
    Bruckner, B.
    Scheinin, S.
    Nguyen, J.
    Seethamraju, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [45] Rejection and Infection Risk After Basiliximab Induction in Low Immunologic-Risk Kidney Transplant Recipients at a High Volume Transplant Center
    Danobeitia, J. S.
    Leverson, G.
    Welch, B.
    Stalter, L.
    Swanson, K.
    Hellner, J.
    Smith, J.
    Parajuli, S.
    Mandelbrot, D.
    Wang, J. Garonzik
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S835 - S836
  • [46] LUNG TRANSPLANT OUTCOMES IN CF PATIENTS AFTER INDUCTION WITH ALEMTUZUMAB
    Pilewski, J.
    Crespo, M.
    Shyu, S.
    Dew, M.
    Bermudez, C.
    Toyoda, Y.
    McCurry, K.
    PEDIATRIC PULMONOLOGY, 2009, : 371 - 371
  • [47] Basiliximab vs. No Induction Therapy in Kidney Transplant Recipients with a Low Immunological Risk Profile Receiving Tacrolimus/Mycophenolate/Steroids Maintenance Immunosuppression
    Lacave, Florian
    de Terwangne, Christophe
    Darius, Tom
    Buemi, Antoine
    Mourad, Michel
    France, Yannick
    Coelho, Joana Cardoso
    Fernandes, Guillaume
    Goffin, Eric
    Devresse, Arnaud
    Kanaan, Nada
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [48] Comparison of 10-year graft failure rates after induction with basiliximab or anti-thymocyte globulin in pediatric heart transplant recipients-The influence of race
    Carlo, Waldemar F.
    Bryant, Roosevelt, III
    Zafar, Farhan
    PEDIATRIC TRANSPLANTATION, 2019, 23 (03)
  • [49] Incidence and significance of noncytomegalovirus viral respiratory infection after adult lung transplantation
    Holt, ND
    Gould, FK
    Taylor, CE
    Harwood, JF
    Freeman, R
    Healy, MD
    Corris, PA
    Dark, JH
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1997, 16 (04): : 416 - 419
  • [50] Rate of opportunistic infection within 3 years after renal transplant using induction with alemtuzumab versus basiliximab.
    Seaman, Jonathan
    Westphal, Scott G.
    Bremers, Doug
    Qiu, Fang
    Florescu, Diana
    TRANSPLANTATION, 2019, 103 (11) : S47 - S47
12345